NCT05889988 2025-11-20
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients
Mayo Clinic
Active not recruiting
Clinical Trials
5 trialsNCT03027245 2022-07-13
IRENE
Eisai Inc.
Completed
NCT01689610 2018-06-20
NABUCCO
iOMEDICO AG
Completed
NCT02606110 2017-07-12
Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Withdrawn
NCT01982591 2017-06-15
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Fox Chase Cancer Center
Completed